Insider filing · ANIP
Ori Gutwerg
SVP, GENERICS
profile →
ANI Pharmaceuticals, Inc.
ANIP · Healthcare · 47 filings in 24 months
ticker →
Ori Gutwerg sold $508K of ANI Pharmaceuticals (ANIP)
Executed Aug 12 2025, disclosed Aug 14 2025, 2 days later.
Value, as filed
$508K
5,873 sh × $86.53
Executed
Aug 12 2025
the trade date, as filed
Disclosed
Aug 14 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
OGOri Gutwerg (SVP, GENERICS) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $243K of ANIP (3,162 sh × $77.00, as filed), executed Aug 10.
The name
ANIPHealthcare · ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Ori Gutwerg in ANIP
ANIPSALE
ANI Pharmaceuticals, Inc.
$243K3,162 sh × $77.00
Exec Aug 10
Filed Aug 11 · 8:57 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $220K
2,772 sh × $79.50
Exec May 12
Filed May 13 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $158K
2,060 sh × $76.50
Exec Mar 3
Filed Mar 4 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $305K
5,084 sh × $60.00
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET